NCT07012395View on ClinicalTrials.gov

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

645

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

March 31, 2028

Conditions
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
Interventions
DRUG

SPY001

Experimental

DRUG

SPY002

Experimental

DRUG

SPY003

Experimental

OTHER

Placebo

Placebo

Trial Locations (49)

3000

RECRUITING

Site 589, Marneuli

4600

RECRUITING

Site 584, Kutaisi

11000

RECRUITING

Site 802, Belgrade

RECRUITING

Site 807, Belgrade

11080

RECRUITING

Site 803, Belgrade

21009

RECRUITING

Site 908, Vinnytsia

21061

RECRUITING

Site 011, Glen Burnie

23000

RECRUITING

Site 801, Zrenjanin

27103

RECRUITING

Site 016, Winston-Salem

27599

RECRUITING

040, Chapel Hill

31000

RECRUITING

Site 806, Užice

33165

RECRUITING

029, Miami

34741

RECRUITING

Site 007, Kissimmee

36011

RECRUITING

Site 914, Poltava

37663

RECRUITING

Site 017, Kingsport

43005

RECRUITING

Site 901, Lutsk

70072

RECRUITING

Site 035, Marrero

71000

RECRUITING

Site 483, Sarajevo

75246

RECRUITING

Site 005, Garland

76008

RECRUITING

Site 906, Ivano-Frankivsk

76092

RECRUITING

Site 008, Southlake

77598

RECRUITING

Site 009, Webster

78229

RECRUITING

Site 002, San Antonio

78613

RECRUITING

Site 013, Cedar Park

79010

RECRUITING

Site 909, Lviv

91304

RECRUITING

Site 024, Canoga Park

RECRUITING

Site 033, Colorado Springs

93534

RECRUITING

Site 012, Lancaster

98405

RECRUITING

Site 019, Tacoma

02904

RECRUITING

Site 025, Providence

0102

RECRUITING

Site 581, Tbilisi

0114

RECRUITING

Site 588, Tbilisi

01444

RECRUITING

Site 583, Tbilisi

0144

RECRUITING

Site 586, Tbilisi

0159

RECRUITING

Site 582, Tbilisi

RECRUITING

Site 587, Tbilisi

0178

RECRUITING

Site 590, Tbilisi

0180

RECRUITING

Site 585, Tbilisi

MD2005

RECRUITING

Site 713, Chisinau

MD2025

RECRUITING

Site 711, Chisinau

RECRUITING

Site 712, Chisinau

RECRUITING

Site 714, Chisinau

MD2068

RECRUITING

Site 715, Chisinau

02002

RECRUITING

Site 902, Kyiv

02091

RECRUITING

Site 904, Kyiv

03037

RECRUITING

Site 905, Kyiv

04050

RECRUITING

Site 913, Kyiv

04107

RECRUITING

Site 911, Kyiv

04210

RECRUITING

Site 903, Kyiv

All Listed Sponsors
lead

Spyre Therapeutics, Inc.

INDUSTRY

NCT07012395 - A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | Biotech Hunter | Biotech Hunter